AI assistant
Sending…
MESA LABORATORIES INC /CO/ — Director's Dealing 2020
Feb 27, 2020
33153_dirs_2020-02-27_3851f87f-0da4-47b7-9756-b84a4a775d01.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MESA LABORATORIES INC /CO (MLAB)
CIK: 0000724004
Period of Report: 2020-02-27
Reporting Person: Sullivan John James (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-02-27 | Common Stock | M | 1494 | $51.85 | Acquired | 72841 | Direct |
| 2020-02-27 | Common Stock | M | 208 | $89.7 | Acquired | 73049 | Direct |
| 2020-02-27 | Common Stock | S | 1702 | $256.02 | Disposed | 71347 | Direct |
| 2020-02-27 | Common Stock | M | 785 | $89.7 | Acquired | 72132 | Direct |
| 2020-02-27 | Common Stock | M | 799 | $70.56 | Acquired | 72931 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-02-27 | Non Qualified Stock Option | $51.85 | X | 1494 | Disposed | 2023-04-01 | Common Stock (1494) | Direct |
| 2020-02-27 | Non Qualified Stock Option | $89.7 | X | 208 | Disposed | 2022-04-01 | Common Stock (208) | Direct |
| 2020-02-27 | Incentive Stock Option | $89.7 | X | 785 | Disposed | 2022-04-01 | Common Stock (785) | Direct |
| 2020-02-27 | Incentive Stock Option | $70.56 | X | 799 | Disposed | 2023-04-01 | Common Stock (799) | Direct |
Footnotes
F1: 1/4 exercisable on each anniverary date of the 04/01/13 grant
F2: 1/7 exercisable on each anniversary date of the 04/01/14 grant date
F3: 1/7 exercisable on each anniversary date of the 4-1-15 grant date
More from MESA LABORATORIES INC /CO/
Regulatory Filings
2026
May 27
Major Shareholding Notification
2026
Apr 15
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 23
Major Shareholding Notification
2026
Mar 13
Regulatory Filings
2026
Mar 9
Regulatory Filings
2026
Feb 3
Interim / Quarterly Report
2026
Feb 3
Director's Dealing
2025
Dec 5
Interim / Quarterly Report
2025
Nov 6